Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2412-2416

  Morfin, Florence ^a   Thouvenot, Danielle ^a   De Turenne Tessier, Mireille ^b   Lina, Bruno ^a   Aymard, Michèle ^a   Ooka, Tadamasa ^b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; THYMIDINE KINASE; THYMINE ARABINOSIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; STOP CODON; VARICELLA ZOSTER VIRUS; VIRAL GENETICS; VIRUS ISOLATION;

EID: 0032879864     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2412     Document Type: Article

References (29)

1. Bean, B., C. Braun, and H. H. Balfour. 1982. Acyclovir therapy for acute herpes zoster. Lancet ii:118-121.
2. Boivin, G., C. K. Edelman, L. Pedneault, C. L. Talarico, K. K. Biron, and H. H. Balfour. 1994. Phenotypic and genotypic characterization of ACV-resistant varicella-zoster viruses isolated from persons with AIDS. J. Infect. Dis. 179:68-75.
3. Chrips, P., and S. P. Clissold. 1991. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 41:104-129.
4. Darby, G., B. A. Larder, and M. M. Inglis. 1986. Evidence that the "active centre" of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J. Gen. Virol. 67:753-758.
5. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
6. De Clercq, E., A. Holy, I. Rosenberg, T. Sakuma, J. Balzarini, and P. C. Maugdal. 1986. A novel selective broad spectrum anti-DNA virus agent. Nature 323:464-467.
7. de Turenne-Tessier, M., T. Ooka, G. de The, and J. Daillie. 1986. Characterization of an Epstein-Barr virus-induced thymidine kinase. J. Virol. 57: 1105-1112.
8. Fillet, A. M., B. Dumont, E. Caumes, B. Visse, H. Agut, F. Bricaire, and J. M. Huraux. 1998. Acyclovir-resistant varicella-zoster virus: phenotypic and genetic characterization. J. Med. Virol. 55:250-254.
9. Gaudreau, A., E. Hill, H. H. Balfour, A. Erice, and G. Boivin. 1998. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178:297-303.
10. Jacobson, M. A., T. G. Berger, S. Fikrig, P. Bechere, J. W. Moohr, S. C. Stanat, and K. K. Biron. 1990. ACV-resistant varicella zoster virus infection after chronic oral ACV therapy in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 112:187-191.
11. Kit, S., M. Sheppard, H. Ichimura, S. Nusinof-Lehrman, M. N. Ellis, J. A. Fyfe, and H. Otsuka. 1987. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acydovir. Antimicrob. Agents Chemother. 31:1483-1490.
12. Kost, R. G., E. L. Hill, M. Tigges, and S. E. Straus. 1993. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N. Engl. J. Med. 329:1777-1782.
13. Langlois, M., J. P. Allard, F. Nugier, and M. Aymard. 1986. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J. Biol. Stand. 14:201-211.
14. Leibovitz, E., A. Kaul, M. Rigaud, D. Bebenroth, K. Krasinski, and W. Borkowsky. 1992. Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature. Cutis 49: 27-31.
15. Linnemann, C. C., K. K. Biron, W. G. Hoppenjans, and A. M. Solinger. 1990. Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS 4:577-579.
16. Lyall, E. G., M. M. Ogilvie, N. M. Smith, and S. Burns. 1994. Acyclovir resistant varicella zoster and HIV infection. Arch. Dis. Child. 70:133-135.
17. Masaoka, T., A. Hiraoka, H. Teshima, and N. Tominaga. 1993. Varicella-zoster virus infection in immunocompromised patients. J. Med. Virol. 41(Suppl. 1):82-84.
18. 17a. Morfin, F., D. Thouvenot, M. Aymard, and B. Lina. 1998. Genetic and phenotypic characterisation of clinical strains of varicella-zoster virus resistant to acyclovir, abstr. H-20a, p. 320. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
19. Nugier, F., J. N. Colin, M. Aymard, and M. Langlois. 1992. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J. Med. Virol 36:1-12.
20. Pahwa, S., K. Biron, W. Lim, P. Swenson, M. H. Kaplan, N. Sadick, and R. Pahwa. 1988. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. J. Virol. 260:2879-2882.
21. Roberts, G. B., J. A. Fyfe, R. K. Gaillard, and S. A. Short. 1991. Mutant varicella-zoster virus lhymidine kinase: correlation of clinical resistance and enzyme impairment. J. Virol. 65:6407-6413.
22. Safrin, S., T. G. Berger, I. Gilson, P. R. Wolfe, C. B. Wofsy, J. Mills, and K. K. Biron. 1991. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann. Intern. Med. 115:19-21.
23. Sawyer, M., G. Inchauspe, K. K. Biron, D. J. Waters, S. E. Straus, and J. M. Ostrove. 1988. Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus. J. Gen. Virol. 69:2585-2593.
24. Shiraki, K., T. Ogino, K. Yamanishi, and M. Takahashi. 1986. Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus. Biken J. 29:7-10.
25. Snoeck, R., M. Gerard, C. Sadzot-Delvaux, G. Andrei, J. Balzarini, D. Reymen, N. Ahadi, J. M. DeBruyn, J. Piette, B. Rentier, N. Clumeck, and E. DeClercq. 1994. Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDS. J. Med. Virol. 42:338-347.
26. Suzutani, T., S. F. Lacey, K. L. Powell, D. J. M. Purifoy, and R. W. Honess. 1992. Random mutagenesis of the thymidine kinase gene of varicella-zoster virus. J. Virol. 66:2118-2124.
27. Talarico, C. L., W. C. Phelps, and K. K. Biron. 1993. Analysis of thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolates from patients with AIDS. J. Virol. 67:1024-1033.
28. Wild, K., T. Bohner, G. Folkers, and G. E. Schulz. 1997. The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci. 6:2097-2106.
29. Wunderli, W., R. Miner, J. Wintsch, S. Von Gunten, H. H. Hirsch, and B. Hirschel. 1996. Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, ganciclovir and sorivudine. Clin. Infect. Dis. 22:864-865.